Recently Added |View All
Video
New Phase 3 Clinical Trial Opens for Pediatric, Adult Hodgkin Lymphoma Patients
While an estimated 95% of “younger” patients diagnosed with Hodgkin lymphoma are still alive and into survivorship within five years of their diagnosis, their long-term health suffers from the aggressive treatment needed to fight the disease.
News
Biomarker-Driven “Umbrella” Study Matches AML, MDS Patients with Specific Clinical Trials
Using bone marrow and blood to identify specific biomarkers, a new “umbrella” screening study matches patients diagnosed with acute myeloid leukemia (AML) or myeloid dysplastic syndrome (MDS) to one of five clinical trials evaluating precision-medicine ...
News
Could Psychedelic Drugs Relieve Cancer Pain?
Roswell Park’s Palliative Care team explores surprising new ways to tackle both the physical and psychological sources of cancer pain.
News
Many patients with early-stage non-small cell lung cancer (NSCLC) are treated post-surgery with the monoclonal antibody durvalumab (brand name Imfinzi) — an FDA-approved regimen.
News
Dr. Mark Farrugia describes new approach to post-operative radiation therapy for non-small cell lung cancer
News
Drug application in review based on trial co-led by Roswell Park’s Dr. Eunice Wang in patients with NPM1-mutant AML.
News
Phase 1 Clinical Trial Offers FDA Fast-Tracked Drug for Relapsed/Refractory AML and MDS
A phase 1 clinical trial underway at Roswell Park Comprehensive Cancer Center offers a promising treatment option for patients with relapsed or refractory acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS).
Video
Clinical CAR T-cell Trial for Multiple Myeloma Suggests Possible “Cure”
For the first time, patients on a new CAR T-cell therapy for multiple myeloma are experiencing remission long enough to be cautious deemed cured of their disease.
News
Research Leaders Across New York State Form Empire State Cellular Therapy Consortium
To expand on early progress in the emerging field of cell and gene therapy, five research centers across New York State are collaborating to develop new cell therapies for cancer and other diseases.
This site is intended for healthcare professionals
Click your preferred app store below to download our free mobile app — exclusively for physicians and physician offices — for direct access to a complete, up-to-date directory of Roswell Park physicians wherever you go. Email or call to refer a patient or ask a question with a click of a button.
BROADCASTMED